Top Markets
Coin of the day
Kailera Therapeutics, Inc. Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA
Kedudukan dalam Saham #5874
Kailera Therapeutics is a biopharmaceutical company currently advancing through... Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
Harga Saham
$18.07
Modal Pasaran
$2.34B
Perubahan (1 hari)
-2.01%
Perubahan (1 tahun)
-
Negara
US
Perdagangan Kailera Therapeutics, Inc. (KLRA)

Kategori

Sejarah hasil dividen untuk Kailera Therapeutics, Inc. (KLRA)
Hasil dividen (TTM) bagi Kailera Therapeutics, Inc. (simbol saham: KLRA) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Kailera Therapeutics, Inc. (KLRA) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH